Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza

The Open Microbiology Journal
Irina V KiselevaLarisa G Rudenko

Abstract

The H5N1 avian influenza was first recognized in humans in Hong Kong 20 years ago. Current enzootic spread of highly pathogenic H5N1 virus among wild and domestic poultry and a number of severe human respiratory diseases caused by this pathogen have stimulated necessity of development of potentially pandemic influenza vaccines. In the past few years, significant research was conducted on how to prevent H5N1 influenza. Live, attenuated cold-adapted reassortant influenza vaccine (LAIV) is considered as one of the most promising candidates for pandemic and prepandemic vaccines. LAIV has proven to be safe and efficacious; pandemic LAIV might be more effective than inactivated vaccine in providing broader immune response. This review covers development of LAIVs against potential avian "pandemic" H5N1 subtype based on cold-adapted A/Leningrad/134/17/57 (H2N2) master donor virus backbone, and their preclinical and clinical studies.

References

Jun 20, 2001·Journal of Virology·G F RimmelzwaanA D Osterhaus
Feb 22, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·L StepanovaA Linde
Jul 20, 2005·Vaccine·Anke HuckriedeJan Wilschut
Oct 22, 2008·The Journal of General Virology·Danielle HickmanDaniel R Perez
May 21, 2009·Influenza and Other Respiratory Viruses·Larisa RudenkoAnton Katlinsky
Jun 3, 2009·Zoonoses and Public Health·P RabinowitzE Mumford
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Qinshan Gao, Peter Palese
Jul 17, 2010·Public Health·W-C TsengL-H Liang
Aug 5, 2011·Clinical and Vaccine Immunology : CVI·T V ChirkovaL G Rudenko
Feb 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Benjamin D GreenbaumRaul Rabadan
Jun 23, 2012·Science·Sander HerfstRon A M Fouchier
Mar 8, 2014·The Journal of Infectious Diseases·Kawsar R TalaatKanta Subbarao
Jan 4, 2015·Expert Review of Vaccines·Larisa Rudenko, Irina Isakova-Sivak
Aug 21, 2015·Expert Review of Vaccines·Irina Isakova-Sivak, Larisa Rudenko
Sep 20, 2015·FEMS Microbiology Reviews·Mathilde Richard, Ron A M Fouchier
Mar 1, 2016·Expert Review of Vaccines·Irina Isakova-SivakLarisa Rudenko

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
ELISA

Related Concepts